Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pherecydes Pharma

Pherecydes Pharma
2006 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$2.99M LATEST DEAL AMOUNT
12 INVESTORS
Description

Operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 102 Avenue Gaston Roussel
  • 93230 Romainville
  • France

+33 01 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Pherecydes Pharma’s full profile, request a free trial.

Pherecydes Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Feb-2018 $2.99M 000.00 Completed Startup
5. Later Stage VC (Series B) 16-Jan-2018 000.00 000.00 Completed Generating Revenue
4. Later Stage VC 18-Mar-2015 00.000 00.000 Completed Generating Revenue
3. Grant 18-Jan-2012 00.000 00.000 Completed Startup
2. Angel (individual) 01-Jan-2007 $3.03M $3.03M Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Pherecydes Pharma Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA 00 00000 0000000000 0 00000
00000 Venture Capital-Backed Ness Ziona, Israel 00 00000 000000000 00000
00000000 Venture Capital-Backed Cambridge, MA 0 000.00 0000000000 0 000.00
00 00000000 Private Debt Financed Paris, France 00 000.00 000000000 000.00
0000000 Private Equity-Backed Houston, TX 00 00.000 000000000000 00.000
To view this company’s complete list of competitors, request access »

Pherecydes Pharma Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizon 2020 Government 000 0000 000000 0
CapDecisif Management Venture Capital Minority 000 0000 000000 0
Elaia Partners Venture Capital Minority 000 0000 000000 0
FaDiese Venture Capital Minority 000 0000 000000 0
GO Capital (France) Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Pherecydes Pharma Executive Team (4)

Name Title Board
Seat
Contact
Info
Guy-Charles de La Horie Chief Executive Officer
Jérôme Gabard Ph.D Chief Operating Officer
Patrick Champion-Arnaud Ph.D Chief Marketing Officer
Cindy Fevre Ph.D Chief Scientific Officer

Pherecydes Pharma Board Members (4)

Name Representing Role Since Contact
Info
Claire Poulard Omnes Capital Supervisory Board Member 000 0000
Emmanuelle Coutanceau Ph.D Auriga Partners (Paris) Board Member 000 0000
Franck Lescure Ph.D Auriga Partners (Paris) Supervisory Board Member 000 0000
Leila Guerlain Nicolas GO Capital (France) Supervisory Board Member 000 0000